• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

    2/10/23 2:42:29 PM ET
    $HWKN
    Specialty Chemicals
    Consumer Discretionary
    Get the next $HWKN alert in real time by email
    SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 4 )*

                

    Hawkins Inc


    (Name of Issuer)

    Common Stock


    (Title of Class of Securities)

    420261109


    (CUSIP Number)

    December 30, 2022


    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X] Rule 13d-1(b)
    [ ] Rule 13d-1(c)
    [ ] Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)


    CUSIP No. 420261109

    1. NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

    Dimensional Fund Advisors LP
    30-0447847
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) [ ]
    (b) [X]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware Limited Partnership

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 1,120,422 ** see Note 1 **
    6. SHARED VOTING POWER 0
    7. SOLE DISPOSITIVE POWER 1,146,463 ** see Note 1 **
    8. SHARED DISPOSITIVE POWER 0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,146,463 ** see Note 1 **
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.5%
    12. TYPE OF REPORTING PERSON

    IA

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    


    Item 1.
    (a) Name of Issuer
    Hawkins Inc
    (b) Address of Issuer's Principal Executive Offices
    2381 Rosegate, Roseville, MN 55113
    Item 2.
    (a) Name of Person Filing
    Dimensional Fund Advisors LP
    (b) Address of Principal Business Office or, if None, Residence
    6300 Bee Cave Road, Building One, Austin, TX 78746
    (c) Citizenship
    Delaware Limited Partnership
    (d) Title of Class of Securities
    Common Stock
    (e) CUSIP Number
    420261109
    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
    (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
    (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
    (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
    (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
    (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).
    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
    (a) Amount Beneficially Owned:
    1,146,463 ** see Note 1 **
    (b) Percent of Class:
    5.5%
    (c) Number of shares as to which such person has:
    (i) sole power to vote or to direct the vote 1,120,422 ** see Note 1 **
    (ii) shared power to vote or to direct the vote 0
    (iii) sole power to dispose or to direct the disposition of 1,146,463 ** see Note 1 **
    (iv) shared power to dispose or to direct the disposition of 0
    ** Note 1 ** Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the "Funds"). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, "Dimensional") may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds, and may be deemed to be the beneficial owner of the shares of the Issuer held by the Funds. However, all securities reported in this schedule are owned by the Funds. Dimensional disclaims beneficial ownership of such securities. In addition, the filing of this Schedule 13G shall not be construed as an admission that the reporting person or any of its affiliates is the beneficial owner of any securities covered by this Schedule 13G for any other purposes than Section 13(d) of the Securities Exchange Act of 1934.
    Item 5. Ownership of Five Percent or Less of Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    The Funds described in Note 1 above have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the securities held in their respective accounts. To the knowledge of Dimensional, the interest of any one such Fund does not exceed 5% of the class of securities. Dimensional Fund Advisors LP disclaims beneficial ownership of all such securities.
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Not Applicable
    Item 8. Identification and Classification of Members of the Group.

    Not Applicable. This schedule is not being filed pursuant to Rule 13d-1(b)(1)(ii)(J) or Rule 13d-1(d).
    Item 9. Notice of Dissolution of Group.

    Not Applicable
    Item 10. Certification.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dimensional Fund Advisors LP
    By: Dimensional Holdings Inc., General Partner
    By: /s/ Selwyn Notelovitz
    Date: February 14, 2023
    Name: Selwyn Notelovitz
    Title: Global Chief Compliance Officer

    Get the next $HWKN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HWKN

    DatePrice TargetRatingAnalyst
    4/14/2025$160.00Neutral → Buy
    BWS Financial
    4/1/2025$125.00Market Outperform
    CJS Securities
    10/16/2024Buy → Neutral
    BWS Financial
    8/7/2023$62.00Neutral → Buy
    BWS Financial
    2/3/2022$44.00 → $52.00Buy
    BWS Financial
    More analyst ratings

    $HWKN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hawkins, Inc. to Participate in the 2025 Wells Fargo Industrials Conference

      ROSEVILLE, Minn., May 20, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, today announced that it will participate in the Wells Fargo Industrials Conference on June 10, 2025. The conference will be held at the Loews Chicago from June 10 to June 12, 2025. The conference will consist of fireside chats and one-on-one meetings with senior executives from leading companies in a variety of industries. Hawkins management will participate on June 10, 2025. For more information about this conference or to schedule a meeting with Hawkins management, please contact the event coordinator or Hawkins Investor Relations at ir@hawkinsinc

      5/20/25 5:04:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

      ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 30, 2025. Fourth Quarter Fiscal Year 2025 Highlights: Record fourth quarter sales of $245.3 million, a 10% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 21% over the same quarter in the prior year.Record fourth quarter gross profit of $52.2 million, a 15% increase over the same quarter of the prior year, contributing to record fourth quarter operating income of $24.6 million, a 22% increase over the prior year.Record fourth quarter diluted earnings per share (EPS) of $0.78, wh

      5/14/25 4:05:49 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share

      ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on May 14, 2025, declared a quarterly cash dividend of $0.18 per share, payable June 13, 2025, to shareholders of record at the close of business on May 30, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 63 facilities in 28 states and

      5/14/25 4:00:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Leadership Updates

    Live Leadership Updates

    See more
    • THE TRŪ® SHRIMP COMPANIES APPOINTS HAWKINS AS EXCLUSIVE U.S. DISTRIBUTOR FOR TRŪ® CHITOSAN

      BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph

      8/16/23 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc.  Announces Retirement of Director John McKeon

      Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020.  Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope.  With his support and guidance, we have built a solid company that is poised for cont

      12/18/20 4:10:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hawkins upgraded by BWS Financial with a new price target

      BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $160.00

      4/14/25 9:28:56 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • CJS Securities initiated coverage on Hawkins with a new price target

      CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00

      4/1/25 9:13:14 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins downgraded by BWS Financial

      BWS Financial downgraded Hawkins from Buy to Neutral

      10/16/24 9:26:58 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    SEC Filings

    See more
    • SEC Form 10-K filed by Hawkins Inc.

      10-K - HAWKINS INC (0000046250) (Filer)

      5/14/25 4:10:18 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - HAWKINS INC (0000046250) (Filer)

      5/14/25 4:08:35 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - HAWKINS INC (0000046250) (Filer)

      4/30/25 4:06:42 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Financials

    Live finance-specific insights

    See more
    • Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

      ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced fourth quarter and full-year results for its fiscal year ended March 30, 2025. Fourth Quarter Fiscal Year 2025 Highlights: Record fourth quarter sales of $245.3 million, a 10% increase over the same quarter of the prior year, led by Water Treatment segment sales growth of 21% over the same quarter in the prior year.Record fourth quarter gross profit of $52.2 million, a 15% increase over the same quarter of the prior year, contributing to record fourth quarter operating income of $24.6 million, a 22% increase over the prior year.Record fourth quarter diluted earnings per share (EPS) of $0.78, wh

      5/14/25 4:05:49 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share

      ROSEVILLE, Minn., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on May 14, 2025, declared a quarterly cash dividend of $0.18 per share, payable June 13, 2025, to shareholders of record at the close of business on May 30, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 63 facilities in 28 states and

      5/14/25 4:00:00 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • HAWKINS, INC. TO RELEASE FOURTH QUARTER AND FISCAL 2025 FINANCIAL RESULTS ON MAY 14, 2025

      ROSEVILLE, Minn., April 30, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) announced today that it expects to release its financial results for its fourth quarter and fiscal year ended March 30, 2025 after the market closes on May 14, 2025 at approximately 4:10 p.m. Eastern Time.  About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Industrial, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 63 facilities in 28 states and creates value for its customers through superb customer service an

      4/30/25 9:00:00 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP of Food and Health Sciences Jones Gregory Alan was granted 3,411 shares, increasing direct ownership by 75% to 7,980 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:47 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • VP-INDUSTRIAL SOLUTIONS GROUP Mangine David J. was granted 3,553 shares, increasing direct ownership by 14% to 29,104 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:44 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • VP - WATER TREATMENT GROUP Lange Douglas A. was granted 3,553 shares, increasing direct ownership by 14% to 28,792 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      5/16/25 4:30:37 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Faulconbridge James A bought $161,899 worth of shares (1,800 units at $89.94), increasing direct ownership by 4% to 47,817 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/14/24 4:09:43 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Director Faulconbridge James A bought $351,036 worth of shares (4,000 units at $87.76), increasing direct ownership by 10% to 46,017 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/12/24 6:02:44 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • Director Faulconbridge James A bought $288,907 worth of shares (3,300 units at $87.55), increasing direct ownership by 9% to 42,017 units (SEC Form 4)

      4 - HAWKINS INC (0000046250) (Issuer)

      6/10/24 4:27:25 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary

    $HWKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hawkins Inc.

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      10/31/24 11:54:59 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      2/13/24 5:06:13 PM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Hawkins Inc. (Amendment)

      SC 13G/A - HAWKINS INC (0000046250) (Subject)

      2/9/24 9:59:13 AM ET
      $HWKN
      Specialty Chemicals
      Consumer Discretionary